That was rivetting. Especially the last few minutes talking about the rate of success of Phylomers compared to small molecule drugs and antibodies.
The hit rate is so high the Big PHARMA are virtually garanteed of getting one of the Phylomers across the line.
They are expecting damn near 100%. Hit rate. Compared to small molecules that might have a 20% success rate.
So with JANSENN deals they are up around $3 BN in Milestones if the success rate is 100%.
Plus. 3-5% Royalties. And they still have 6 Of the Top Ten to sign.
I know this company is well out of favor, but looks like the heard have galloped of after the next big winner. And left behind a company that is almost there for hitting it's rerating points within the next 12 Months.
I really doubt the brokers who attended the lunch would be smart enough to even understand what was just presented tO them
PYC Price at posting:
4.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)